Asia Pacific Veterinary Vaccines Market Report and Forecast 2024-2032

Asia Pacific Veterinary Vaccines Market Report and Forecast 2024-2032


Market Outlook

According to the report by Expert Market Research (EMR), the Asia Pacific veterinary vaccines market is projected to grow at a CAGR of 6.60% between 2024 and 2032. Aided by the burgeoning demand for quality animal-derived products and the escalating significance of animal health, the market is expected to grow significantly by 2032.

Veterinary vaccines play an indispensable role in the safeguarding of animal health, ensuring the prevention of various diseases that afflict livestock, poultry, and companion animals. These vaccines not only assure the vitality and well-being of the animals but also considerably impact the safety and quality of animal-derived products such as meat, milk, and eggs. Beyond their primary role in disease prevention, veterinary vaccines have also demonstrated efficacy in curbing the transmission of zoonotic diseases to humans, thereby establishing a multifaceted significance in the holistic health framework.

The Asia Pacific, with its vast expanse and diverse culinary palette, witnesses a profound reliance on animal-derived products, which influences the Asia Pacific veterinary vaccines market outlook. This heavy demand invariably emphasises the health and well-being of livestock and poultry, thrusting veterinary vaccines into the limelight. As consumers in the region become increasingly health-conscious and discerning about the provenance and quality of their food, the livestock industry faces mounting pressure to ensure the health, productivity, and disease-resistance of their animals, fuelling the demand for efficient and advanced veterinary vaccines.

Additionally, the rise in pet adoption across urban areas in countries like Japan, Australia, China, and India further propels the Asia Pacific veterinary vaccines market growth. As pets become an integral part of family units, there's a growing awareness and willingness among pet owners to invest in preventive healthcare, including regular vaccination.

The region is also a hotspot for several infectious animal diseases due to its diverse climatic conditions and dense animal population. Outbreaks of diseases such as Avian Influenza, Foot-and-Mouth Disease, and Swine Fever have historically impacted the region. These challenges underline the pressing need for advanced and comprehensive vaccination strategies, thereby spurring the veterinary vaccine industry's growth.

According to the Asia Pacific veterinary vaccines market analysis, veterinary vaccines have witnessed significant advancements in the pharmaceutical spectrum. Biotechnological innovations have led to the development of recombinant vaccines, DNA vaccines, and marker vaccines. Such innovations are instrumental in enhancing the efficacy, safety, and specificity of veterinary vaccines, catering to the dynamic needs of the Asia Pacific market.

Market Segmentation

The market can be divided based on vaccine type, route of administration, distribution channels, and country.

Market Breakup by Vaccine Type
  • Livestock Vaccines
Porcine Vaccines

Bovine Vaccines

Poultry Vaccines

Others
  • Companion Animal Vaccines
Canine Vaccines

Feline Vaccines

Equine Vaccines

Others
  • Others
Market Breakup by Route of Administration
  • Oral
  • Parenteral
  • Others
Market Breakup by Distribution Channels
  • Veterinary Hospitals and Clinics
  • Pharmacies and Drug Stores
  • Online
  • Others
Market Breakup by Country
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Australia
  • Others
Competitive Landscape

The EMR report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the Asia Pacific veterinary vaccines market. Some of the major players explored in the report by Expert Market Research are as follows:
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Inc
  • Zoetis Services LLC
  • Merck & Co., Inc.
  • Ceva Santé Animale
  • Hester Biosciences Limited
  • QYH Biotech Co., Ltd.
  • Kyoto Biken Laboratories, Inc.
  • PT JAPFA COMFEED INDONESIA Tbk.
  • Medion Farma
  • Zuellig Pharma Limited
  • PT Kalbe Farma Tbk.
  • Others
About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.

*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Market Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Industry Opportunities and Challenges
8 Asia Pacific Veterinary Vaccines Market Analysis
8.1 Key Industry Highlights
8.2 Asia Pacific Veterinary Vaccines Historical Market (2018-2023)
8.3 Asia Pacific Veterinary Vaccines Market Forecast (2024-2032)
8.4 Asia Pacific Veterinary Vaccines Market by Vaccine Type
8.4.1 Livestock Vaccines
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.1.4 Breakup by Type
8.4.1.4.1 Porcine Vaccines
8.4.1.4.2 Bovine Vaccines
8.4.1.4.3 Poultry Vaccines
8.4.1.4.4 Others
8.4.2 Companion Animal Vaccines
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.2.4 Breakup by Type
8.4.2.4.1 Canine Vaccines
8.4.2.4.2 Feline Vaccines
8.4.2.4.3 Equine Vaccines
8.4.2.4.4 Others
8.4.3 Others
8.5 Asia Pacific Veterinary Vaccines Market by Route of Administration
8.5.1 Oral
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Parenteral
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Others
8.6 Asia Pacific Veterinary Vaccines Market by Distribution Channels
8.6.1 Veterinary Hospitals and Clinics
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Pharmacies and Drug Stores
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Online
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2023)
8.6.3.3 Forecast Trend (2024-2032)
8.6.4 Others
8.7 Asia Pacific Veterinary Vaccines Market by Country
8.7.1 Market Share
8.7.1.1 China
8.7.1.2 Japan
8.7.1.3 India
8.7.1.4 South Korea
8.7.1.5 Indonesia
8.7.1.6 Thailand
8.7.1.7 Australia
8.7.1.8 Others
9 Regional Analysis
9.1 China
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Japan
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.3 India
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.4 South Korea
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.5 Indonesia
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.6 Thailand
9.6.1 Historical Trend (2018-2023)
9.6.2 Forecast Trend (2024-2032)
9.7 Australia
9.7.1 Historical Trend (2018-2023)
9.7.2 Forecast Trend (2024-2032)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Boehringer Ingelheim International GmbH
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Elanco Animal Health Inc
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Zoetis Services LLC
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Merck & Co., Inc.
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Ceva Santé Animale
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Hester Biosciences Limited
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 QYH Biotech Co., Ltd.
11.2.7.1 Company Overview
11.2.7.2 Product Portfolio
11.2.7.3 Demographic Reach and Achievements
11.2.7.4 Certifications
11.2.8 Kyoto Biken Laboratories, Inc.
11.2.8.1 Company Overview
11.2.8.2 Product Portfolio
11.2.8.3 Demographic Reach and Achievements
11.2.8.4 Certifications
11.2.9 PT JAPFA COMFEED INDONESIA Tbk.
11.2.9.1 Company Overview
11.2.9.2 Product Portfolio
11.2.9.3 Demographic Reach and Achievements
11.2.9.4 Certifications
11.2.10 Medion Farma
11.2.10.1 Company Overview
11.2.10.2 Product Portfolio
11.2.10.3 Demographic Reach and Achievements
11.2.10.4 Certifications
11.2.11 Zuellig Pharma Limited
11.2.11.1 Company Overview
11.2.11.2 Product Portfolio
11.2.11.3 Demographic Reach and Achievements
11.2.11.4 Certifications
11.2.12 PT Kalbe Farma Tbk.
11.2.12.1 Company Overview
11.2.12.2 Product Portfolio
11.2.12.3 Demographic Reach and Achievements
11.2.12.4 Certifications
11.2.13 Others
12 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Asia Pacific Veterinary Vaccine Market: Key Industry Highlights, 2018 and 2032
2. Asia Pacific Veterinary Vaccine Historical Market: Breakup by Vaccine Type (USD Million), 2018-2023
3. Asia Pacific Veterinary Vaccine Market Forecast: Breakup by Vaccine Type (USD Million), 2024-2032
4. Asia Pacific Veterinary Vaccine Historical Market: Breakup by Route of Administration (USD Million), 2018-2023
5. Asia Pacific Veterinary Vaccine Market Forecast: Breakup by Route of Administration (USD Million), 2024-2032
6. Asia Pacific Veterinary Vaccine Historical Market: Breakup by Distribution Channels (USD Million), 2018-2023
7. Asia Pacific Veterinary Vaccine Market Forecast: Breakup by Distribution Channels (USD Million), 2024-2032
8. Asia Pacific Veterinary Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
9. Asia Pacific Veterinary Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Asia Pacific Veterinary Vaccine Market Structure

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings